(Q53322874)

13 May 2018

title

Cancer of the corpus uteri. (English)

1 reference

13 May 2018

author

Carien L Creutzberg

4

1 reference

13 May 2018

Frédéric Amant

1

object named as

Frédéric Amant

1 reference

13 May 2018

author name string

Mansoor Raza Mirza

2

1 reference

13 May 2018

Martin Koskas

3

1 reference

13 May 2018

publication date

1 October 2015

1 reference

13 May 2018

International Journal of Gynecology and Obstetrics

published in

1 reference

13 May 2018

volume

131 Suppl 2

1 reference

13 May 2018

page(s)

S96-104

1 reference

13 May 2018

Significance of lymphovascular space invasion in uterine serous carcinoma: what matters more; extent or presence?

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2015.06.005

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2015.06.005

21 January 2018

Cancer statistics, 2015

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2015.06.005

State of the epidemiological evidence on physical activity and cancer prevention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2015.06.005

Physical activity and gynecologic cancer prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2015.06.005

Obesity and age at diagnosis of endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2015.06.005

Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2015.06.005

Trends in corpus uteri cancer mortality in member states of the European Union.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2015.06.005

Recent changes in endometrial cancer trends among menopausal-age U.S. women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2015.06.005

The behavior of endometrial hyperplasia. A long-term study of "untreated" hyperplasia in 170 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2015.06.005

Sensitivity of transvaginal ultrasound screening for endometrial cancer in postmenopausal women: a case-control study within the UKCTOCS cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2015.06.005

Cancer screening in the United States, 2009: a review of current American Cancer Society guidelines and issues in cancer screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2015.06.005

Predictive value of magnetic resonance imaging in assessing myometrial invasion in endometrial cancer: is radiological staging sufficient for planning conservative treatment?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2015.06.005

Intraoperative frozen section is essential for assessment of myometrial invasion but not for histologic grade confirmation in endometrial cancer: a ten-year experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2015.06.005

Estimating the depth of myometrial involvement by endometrial carcinoma: efficacy of transvaginal sonography vs MR imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2015.06.005

Imaging in endometrial cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2015.06.005

Laparoscopy compared with laparotomy for comprehensive surgical staging of uterine cancer: Gynecologic Oncology Group Study LAP2

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2015.06.005

Safety of laparoscopy versus laparotomy in early-stage endometrial cancer: a randomised trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2015.06.005

Improved surgical safety after laparoscopic compared to open surgery for apparent early stage endometrial cancer: Results from a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2015.06.005

Recurrence and survival after random assignment to laparoscopy versus laparotomy for comprehensive surgical staging of uterine cancer: Gynecologic Oncology Group LAP2 Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2015.06.005

Surgical outcome of robotic surgery in morbidly obese patient with endometrial cancer compared to laparotomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2015.06.005

Survival analysis of robotic versus traditional laparoscopic surgical staging for endometrial cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2015.06.005

Comparative effectiveness of robotic versus laparoscopic hysterectomy for endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2015.06.005

Influence of gynecologic oncologists on the survival of patients with endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2015.06.005

Impact of wait times on survival for women with uterine cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2015.06.005

Time interval between endometrial biopsy and surgical staging for type I endometrial cancer: association between tumor characteristics and survival outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2015.06.005

Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2015.06.005

Endometrial cancer--revisiting the importance of pelvic and para aortic lymph nodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2015.06.005

Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2015.06.005

Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2015.06.005

Survival after relapse in patients with endometrial cancer: results from a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2015.06.005

Quality of life after pelvic radiotherapy or vaginal brachytherapy for endometrial cancer: first results of the randomized PORTEC-2 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2015.06.005

Omitting adjuvant radiotherapy in endometrial cancer increases the rate of locoregional recurrences but has no effect on long-term survival: the Danish Endometrial Cancer Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2015.06.005

Treatment preferences and involvement in treatment decision making of patients with endometrial cancer and clinicians.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2015.06.005

Sequential adjuvant chemotherapy and radiotherapy in endometrial cancer--results from two randomised studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2015.06.005

Adjuvant chemotherapy vs radiotherapy in high-risk endometrial carcinoma: results of a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2015.06.005

Adjuvant progestagen therapy for the treatment of endometrial cancer: review and meta-analyses of published randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2015.06.005

Surgery for endometrial cancers with suspected cervical involvement: is radical hysterectomy needed (a GOTIC study)?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2015.06.005

Node-positive adenocarcinoma of the endometrium: outcome and patterns of recurrence with and without external beam irradiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2015.06.005

A randomized phase III trial in advanced endometrial carcinoma of surgery and volume directed radiation followed by cisplatin and doxorubicin with or without paclitaxel: A Gynecologic Oncology Group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2015.06.005

Cytoreductive surgery for advanced or recurrent endometrial cancer: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2015.06.005

Neoadjuvant chemotherapy followed by interval debulking surgery in patients with serous endometrial cancer with transperitoneal spread (stage IV): a new preferred treatment?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2015.06.005

Phase III trial of doxorubicin plus cisplatin with or without paclitaxel plus filgrastim in advanced endometrial carcinoma: a Gynecologic Oncology Group Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2015.06.005

Phase III trial of doxorubicin with or without cisplatin in advanced endometrial carcinoma: a gynecologic oncology group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2015.06.005

Carboplatin and paclitaxel for the treatment of advanced or recurrent endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2015.06.005

Endometrial cancer: what is new in adjuvant and molecularly targeted therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2015.06.005

Anticancer chemosensitization and radiosensitization by the novel poly(ADP-ribose) polymerase-1 inhibitor AG14361.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2015.06.005

Phase II study of temsirolimus in women with recurrent or metastatic endometrial cancer: a trial of the NCIC Clinical Trials Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2015.06.005

A phase 2 study of the oral mammalian target of rapamycin inhibitor, everolimus, in patients with recurrent endometrial carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2015.06.005

What Is the Evidence That Tumors Are Angiogenesis Dependent?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2015.06.005

Vascular endothelial growth factor is a secreted angiogenic mitogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2015.06.005

Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2015.06.005

The biology of VEGF and its receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2015.06.005

Vascular permeability factor (VPF)/vascular endothelial growth factor (VEGF) peceptor-1 down-modulates VPF/VEGF receptor-2-mediated endothelial cell proliferation, but not migration, through phosphatidylinositol 3-kinase-dependent pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2015.06.005

Phase II trial of bevacizumab in recurrent or persistent endometrial cancer: a Gynecologic Oncology Group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2015.06.005

A phase II trial of paclitaxel, carboplatin, and bevacizumab in advanced and recurrent endometrial carcinoma (EMCA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2015.06.005

Phase II trial of combination bevacizumab and temsirolimus in the treatment of recurrent or persistent endometrial carcinoma: a Gynecologic Oncology Group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2015.06.005

A phase II evaluation of gefitinib in the treatment of persistent or recurrent endometrial cancer: a Gynecologic Oncology Group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2015.06.005

Phase II study of everolimus and letrozole in patients with recurrent endometrial carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2015.06.005

Phase II trial of trastuzumab in women with advanced or recurrent, HER2-positive endometrial carcinoma: a Gynecologic Oncology Group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2015.06.005

Primary radiation therapy for medically inoperable patients with clinical stage I and II endometrial carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2015.06.005

Prognostic factors of oncologic and reproductive outcomes in fertility-sparing management of endometrial atypical hyperplasia and adenocarcinoma: systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2015.06.005

Endometrial carcinoma--relative effectiveness of adjuvant irradiation vs therapy reserved for relapse

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2015.06.005

Follow-up after primary therapy for endometrial cancer: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2015.06.005

The role of routine follow-up after gynecological malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2015.06.005

Recurrence patterns and surveillance for patients with early stage endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2015.06.005

Pattern of failure and value of follow-up procedures in endometrial and cervical cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2015.06.005

Postsurgical surveillance of patients with FIGO stage I/II endometrial adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2015.06.005

Transvaginal ultrasonography of the endometrium in women with postmenopausal bleeding — a Nordic multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2015.06.005

Randomized Phase III Trial of Whole-Abdominal Irradiation Versus Doxorubicin and Cisplatin Chemotherapy in Advanced Endometrial Carcinoma: A Gynecologic Oncology Group Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2015.06.005

10.1016/J.IJGO.2015.06.005

21 January 2018

Identifiers

DOI

1 reference

13 May 2018

PubMed ID

26433681

1 reference

13 May 2018